We are live on ! Find out more
MBIN icon

Merchants Bancorp

57 hedge funds and large institutions have $131M invested in Merchants Bancorp in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more capital invested

Capital invested by funds: $119M → $131M (+$11.7M)

0.16% more ownership

Funds ownership: 31.63%31.79% (+0.16%)

3% less funds holding

Funds holding: 5957 (-2)

18% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 11

18% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 22

Holders
57
Holders Change
-2
Holders Change %
-3.39%
% of All Funds
1.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
18
Reduced
22
Closed
11
Calls
Puts
Net Calls
Net Calls Change

MBIN Hedge Fund Activity: Q1 2018 in Review

57 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Merchants Bancorp (MBIN) for Q1 2018, worth a combined $131M — up 9.8% from $119M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of MBIN and 9 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 18 added.

The largest buyer was Ameriprise, opening a new position worth an estimated $6.07M. The largest seller was Basswood Capital Management, cutting an estimated $6.5M.

  • 57 institutional investors held Merchants Bancorp (MBIN) as of Q1 2018, down from 59 in Q4 2017.
  • Funds reported $131M of Merchants Bancorp stock for Q1 2018, up 9.8% quarter-over-quarter.
  • 9 funds opened new Merchants Bancorp positions in Q1 2018 and 11 closed out, a net change of -2 holders.
  • The largest Merchants Bancorp buyer in Q1 2018 was Ameriprise, an estimated $6.07M added.
  • The largest Merchants Bancorp seller in Q1 2018 was Basswood Capital Management, an estimated $6.5M sold.

Based on aggregated 13F filings for Q1 2018.